Proteins are susceptible to attack by reactive oxygen species (ROS). Several types of ROS-induced protein damage have been identified, including amino acid modification, cross-linking, and degradation. 1, 2) Glutathione (GSH) is the major intracellular non-protein thiol compound and plays a key role in the protection of cells and tissue structures from oxidative injury. GSH can exist in a reduced form (GSH), oxidized form (GSSG), or as proteinbound GSH (GSSP). GSH acts as an intracellular antioxidant that is involved in preventing protein sulfhydryl groups from oxidizing and cross-linking. In addition, the GSH redox system functions indirectly with glutaredoxin (Grx), glucose 6-phosphate dehydrogenase (G6PDH), and glutathione reductase (GR), which maintain GSH in its reduced form. An increase in oxidative stress leads to the oxidation of GSH to GSSG and, under certain conditions, the formation of glutathionyl proteins. Various glutathionyl proteins are involved in numerous physical processes (e.g., growth, differentiation, cell cycle progression, cytoskeletal functions, and metabolism), suggesting that S-glutathionylation is a general mechanism of redox regulation. [3] [4] [5] Red blood cells (RBCs) have been used as a model system in numerous studies to determine the significance of the GSH-dependent redox system 6,7) because they have an efficient antioxidant defense system that prevents oxidative damage.
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Glutathione (GSH) is the major intracellular non-protein thiol compound and plays a key role in the protection of cells and tissue structures from oxidative injury. GSH can exist in a reduced form (GSH), oxidized form (GSSG), or as proteinbound GSH (GSSP). GSH acts as an intracellular antioxidant that is involved in preventing protein sulfhydryl groups from oxidizing and cross-linking. In addition, the GSH redox system functions indirectly with glutaredoxin (Grx), glucose 6-phosphate dehydrogenase (G6PDH), and glutathione reductase (GR), which maintain GSH in its reduced form. An increase in oxidative stress leads to the oxidation of GSH to GSSG and, under certain conditions, the formation of glutathionyl proteins. Various glutathionyl proteins are involved in numerous physical processes (e.g., growth, differentiation, cell cycle progression, cytoskeletal functions, and metabolism), suggesting that S-glutathionylation is a general mechanism of redox regulation. [3] [4] [5] Red blood cells (RBCs) have been used as a model system in numerous studies to determine the significance of the GSH-dependent redox system 6, 7) because they have an efficient antioxidant defense system that prevents oxidative damage. [8] [9] [10] Moreover, RBCs have high levels of GSH and Grx, which are thought to utilize the reducing power of GSH to catalyze disulfide reductions in the presence of reduced nicotinamide adenine dinucleotide phosphate (NADPH) and GR. 11) Many lines of evidence have emerged to support a fundamental role for the glutathionylation of certain proteins in normal cellular biochemical and physiological processes. It has been reported that some proteins are capable of reacting to form the glutathionyl protein. In particular, it is well known that actin 12) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 13) are oxidized to form glutathionyl proteins. Additionally, the formation of glutathionyl proteins in human RBCs has been reported in in vitro studies. These studies indicated that hemoglobin, GAPDH and actin, 14) as well as spectrin and membrane protein band 4.2, 15) are glutathionylated in response to diamide or ROS. Alternatively, GSH is likely to contribute to the protection of all thiol residues in proteins against ROS in the cell. However, the physiological susceptibility of proteins to ROS and the direct effects of GSH on oxidative stress in human RBCs remain poorly understood. Moreover, there is little information on the significance of redox regulation that is dependent on the glutathionylation of individual proteins.
The objective of this study was to identify physiologically relevant glutathionyl proteins formed in RBCs by ROS exposure. Therefore, we designed experiments to disrupt GSH homeostasis. 16) We used two independent treatments aimed at decreasing the level of the reduced form of GSH concretely: 1) pre-incubation with a GR inhibitor and 2) a glucose-free medium to examine the influences of preventing GSHdependent antioxidant and reducing activity to reduce glutathionyl proteins in the cells. When GSH levels failed to recover after tert-butyl hydroperoxide (BHP) exposure, we clearly detected the formation of glutathionyl protein in human RBCs after pre-treatment aimed at disrupting GSH homeostasis and subsequent BHP exposure.
MATERIALS AND METHODS
Chemicals BHP, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), human erythroid spectrin (aϩb), and GSSG were purchased from Sigma Chemical Co. Dithiothreitol (DTT) and Wideview TM prestain protein size marker II were obtained from Wako Pure Chemical Co. (Osaka, Japan). Bovine serum albumin and protease inhibitor cocktail were purchased from Roche Diagnosis GmbH (Mannheim, Germany). The primary anti-GSH monoclonal antibody was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.), anti-human erythroid spectrin monoclonal antibody was obtained from LifeSpan BioSciences (Seattle, WA, U.S.A.), and secondary goat anti-mouse immunoglobulin G (IgG) and goat anti-rabbit IgG (horseradish peroxidase conjugates) were purchased from Vector Co. (Burlingame, CA, U.S.A.). High molecular weight size marker (HiMark Unstained High Molecular Weight Protein Standard) and Western blotting marker (MagicMark XP) were purchased from Invitrogen Co. (Carlsbad, CA, U.S.A.). Protein G-Sepharose was obtained from Millipore (Tokyo, Japan). All other reagents were of the highest grade commercially available.
Preparation of Human RBC Suspensions Blood samples were obtained from eight healthy subjects (aged 22-46) after 12 h fasting and with informed consent. Blood was drawn into Vacutainer tubes containing ethylenediamine tetraacetic acid (EDTA). RBCs were prepared by centrifugation for 15 min at 800 g and 4°C and were washed twice in phosphate-buffered saline (PBS) with the same centrifugation procedures. RBC suspensions were prepared by adding PBS in the presence or absence of 10 mM glucose. The hematocrit of each RBC suspension was adjusted to 40% (Hct. 0.40). All experiments were performed on the day that the blood was drawn.
Exposure of RBC Suspensions to BHP To determine the effects of BHP on RBCs, RBC suspensions containing 10 mM glucose were incubated at 37°C with 2.0 mM BHP for 5, 15, and 60 min, after which the RBCs were washed twice to remove extracellular BHP. The RBC pellet was then lysed by the addition of eight volumes of sterilized distilled water, which was followed by the addition of one volume of 10-fold concentrated PBS to condition the lysate.
Preparation of RBC Membranes (White Ghosts) Erythrocyte ghosts were prepared from washed RBCs according to the method of Dodge et al. 17) with some modifications. Briefly, the RBC pellets were hemolysed on ice with 20 volumes of 10 mM phosphate buffer (pH 7.4) and centrifuged for 20 min at 18000 g and 4°C. The ghosts were resuspended in ice-cold 5 mM phosphate buffer (pH 7.4), and this process was continued until the washing buffer became colorless. The ghosts were finally resolved in PBS containing 1.0% sodium dodecyl sulfate (SDS).
Disruption of GSH Homeostasis RBC suspensions (hematocrit (Hct.) 0.40) were pre-incubated at 37°C in the presence or absence of 1 mM BCNU in PBS containing 10 mM glucose. GR activity in RBC was inhibited by 90% after this treatment. After a 30 min incubation, each suspension was washed twice with PBS containing glucose. Ten microliters of BHP was then added to 0.49 ml of the RBC suspension, followed by incubation at 37°C for various times.
RBCs with low intracellular glucose levels (less than 2.0 mM per RBC) were prepared by pre-incubation for 45 min at 37°C in a PBS suspension in the absence of glucose. The glucose level in RBCs decreased to less than 2.0 mM with this treatment. Each RBC suspension (Hct. 0.40) was then incubated in the presence or absence of 2.0 mM BHP for various times.
Determination of GSH, GSSG, and GSSP RBCs in suspension (Hct. 0.40) were centrifuged, and the packed cells were lysed by the addition of eight volumes of distilled water and the immediate addition of one volume of 25% (w/v) sulfosalicylic acid. After centrifugation for 5 min at 15000 g, the clear supernatant was used for the determination of GSH. GSH was measured by a HPLC method, as previously reported, 18) with minor modifications. Briefly, the clear supernatants (10 ml) of acid-treated samples were neutralized by the addition of four volumes of 0.2 M borate buffer (pH 10.5), and labeling reagent was then added to the mixture (50 ml). 19) with minor modifications. At the indicated time points, an aliquot (200 ml) of the RBC suspension was removed and centrifuged at 800 g for 10 min at 4°C. An aliquot (50 ml) of the pelleted RBCs was hemolysed by adding 1 ml of 10 mM phosphate buffer (pH 7.4). After gentle mixing, the hemolysate was centrifuged at 18000 g for 20 min at 4°C. Clarified supernatant (100 ml) was taken to determine the GSSP content in the cytosolic fraction. Alternatively, the pellets obtained after centrifugation were resuspended in ice-cold 5 mM phosphate buffer (pH 7.4) to prepare white ghost solutions. Samples were immediately processed by deproteinization with 4 vol. of ice-cold 5% (w/v) metaphosphoric acid, and the pellets were washed twice with 5% metaphosphoric acid with centrifugation for 5 min at 10000 g. After a final wash, the pellets were resuspended in 8 M urea containing 1 mM EDTA. Reductions were performed by borohydride. After reduction and filtration, the solutions were diluted with a 0.2 M borate buffer (pH 10.5), followed by pre-labeling with 4-fluoro-7-sulfamoylbenzofurazan (ABD-F) for the HPLC assay.
18)
Effects of BHP Concentration on GSSP Formation in Human RBCs BHP (0.5-3 mM) were added to the RBC suspensions (Hct. 0.40) and incubated at 37°C for 60 min. An aliquot (100 ml) of the RBC suspension was removed at the indicated time points, and centrifuged at 800 g for 10 min at 4°C. The pelleted RBCs were immediately hemolysed by adding nineteen volumes of ice-cold 10 mM phosphate buffer (pH 7.4), followed by vigorous vortexing. After preparation of RBC membrane resolved in PBS containing 1.0% SDS, aliquots (100 ml) of the ghost solution were analysed by HPLC to determine protein-bound GSH (GSSP) concentration.
Analyses of the Membrane Protein by BHP Exposure The RBC membrane fractions were separated by SDS-polyacrylamide gel electrophoresis (PAGE), with a 5-20% gradient gel under reducing (DTT-containing SDS buffer) or non-reducing conditions. RBC membrane samples were prepared from RBC suspensions (Hct. 0.4) exposed to 2 mM BHP with or without pre-treatment with 1 mM BCNU. Protein bands were visualized by staining with Coomassie brilliant blue (CBB) R-250. Major proteins are numbered according to Steck. 20) Western-Blot Analyses and Immunoprecipitation For whole RBC samples, a 50 ml portion of the RBC suspension (Htc. 0.40) was mixed vigorously with 0.95 ml of DTT-con-taining (reducing) or DTT-free (non-reducing) SDS buffer to confirm whether the detected signal was caused by S-glutathionylation. RBC membrane samples were prepared from RBC suspensions (Hct. 0.40) under reducing or non-reducing conditions. The non-reducing and reducing samples were run on SDS-PAGE gels using high molecular weight markers (unstained) and pre-stained Western blotting markers as molecular-mass standards. The proteins were separated by SDS-PAGE on 3-10% gels and then transferred to polyvinylidene difluoride (PVDF) membrane filters, as described. For the staining of glutathionyl proteins, the transferred membranes were blocked with 5% skim milk in TPBS [(0.1% (v/v) Tween-containing PBS, pH 7.4)] and then washed three times with TPBS. Washed PVDF filters were then incubated for 1 h at room temperature with the primary anti-GSH antibody (1 : 1500 dilution in TPBS). After extensive washing in TPBS, the blots were incubated at room temperature for 1 h with anti-mouse IgG horseradish peroxidase-conjugated secondary antibody (1 : 5000 dilution). Bands were visualized by chemiluminescence (Luminol/Enhancer solution; Roche Diagnostics GmbH, Mannheim, Germany) and subsequent exposure to Hyperfilm TM ECL (GE Healthcare Ltd., Buckinghamshire, U.K.).
The control and BHP-treated RBCs (Hct. 0.40) were hemolysed in immunoprecipitation buffer (10 mM N-(2-hydroxyethyl)piperazine-NЈ-2-ethanesulfonic acid (HEPES), pH 7.4, containing 0.5% NP-40, 0.15 M NaCl, 1 mM EDTA, and a protease inhibitor cocktail), and the hemolysate was used in immunoprecipitation experiments with protein G-Sepharose conjugated with an anti-human erythroid spectrin monoclonal antibody. Concretely, 2 mg of the anti-spectrin antibody was added to a 30 ml aliquot of 50% (v/v) protein-G slurry. This mixture was incubated at 4°C for 6 h to generate protein-G-antibody conjugates. An equal amount of nontreated hemolysate was used for the immunoprecipitation assay. The pellet containing the protein-G-antibody-antigen conjugate was mixed with gel loading buffer, incubated at 95°C for 5 min, and centrifuged to collect the supernatant. These immunoprecipitated samples were run on a 3-10% SDS-PAGE gel and transferred to PVDF membranes. The PVDF membranes were processed using the primary anti-GSH antibody, as described above. After the detection of glutathionyl proteins, the membrane was incubated in a stripping buffer for 30 min at 50°C and washed three times with TPBS. The stripped membrane was reprobed for total spectrin using a mouse monoclonal antibody against spectrin and a goat anti-mouse horseradish peroxidase-coupled secondary antibody to demonstrate actual protein (immunoprecipitated spectrins) loading into the gel.
Other Methods The protein concentration was assayed by the method of Lowry et al. 21) using bovine serum albumin (BSA) as a standard (Bio-Rad Protein Assay Kit). SDS-PAGE was performed according to the procedure of Laemmli. 22) RBC glucose concentrations were determined by an enzymatic method using a glucose test kit (Wako Pure Chemical Co.).
Statistics Data are expressed as the meanϮS.D. and were compared using a Student's t-test. Results were considered statistically significant when pϽ0.05.
RESULTS

Alterations in GSH Homeostasis upon Exposure of RBCs to BHP
In the presence of sufficient glucose, GSH levels in intact RBCs transiently decreased and then increased upon exposure to BHP but rapidly recovered within 1 h (Fig.  1) . BCNU, an inhibitor of GR, 23) was used to decrease GSH levels in RBCs. After treatment with 1 mM BCNU and 10 mM glucose, the RBC suspension was exposed to BHP and incubated for 1 h in the presence of glucose. As shown in Fig. 1 , a clear decrease in GSH without recovery was observed in BCNU-treated RBCs exposed to BHP. After incubation of the RBC suspension for 45 min in the absence of glucose, subsequent addition of BHP also resulted in significantly decreased GSH, which did not recover after 1 h, as shown in Fig. 1 .
Conversely, GSSG and GSSP levels in intact RBCs transiently increased upon exposure to BHP but decreased within 60 min (Figs. 2A, D) . After treatment with 1 mM BCNU and 10 mM glucose, the RBC suspension was exposed to BHP and incubated for 1 h in the presence of glucose. As shown in Fig. 2 , clear increases in GSSG (Fig. 2B) and GSSP (Fig. 2E ) levels without return were observed in RBCs exposed to BHP.
After incubation of the RBC suspension for 45 min in the absence of glucose, subsequent addition of BHP resulted in significantly increased GSSG (Fig. 2C) and GSSP (Fig. 2F ) levels, which did not recover after 1 h.
Detection of Glutathionyl Proteins in RBCs after
Exposure to BHP When the whole RBCs were examined by Western blotting analysis using anti-GSH antibody, the high molecular weight (220-240 kDa) protein was transiently detected in a non-reduced sample, and glutathionyl protein was not observed in a reduced sample treated with 0.1 M DTT prior to SDS-PAGE (Fig. 3) . Additionally, the high molecular weight glutathionyl protein (220-240 kDa) disappeared at 60 min of incubation under non-reducing conditions. Also, faint bands (48 kDa) were observed in non-reduced sample at 15 min and 60 min, however the detection of this protein band lacked reproducibility in the replicated experiments. Although two bands were observed in the low molecular weight range (29-35 kDa) during Western blot analysis (Fig.  3) , these bands seemed to be non-specific because they did not disappear with 0.1 M DTT which completely reduce the disulfide bonds and release GSH, and they were also detected without BHP exposure (0 min). These results indicate that very low level of S-glutathionylation occurs in normal human RBCs and that glutathionyl proteins are produced by ROS exposure. Furthermore, it was observed that glutathione bound to protein by disulfide bonds is immediately released in normal RBCs in the presence of sufficient glucose. Figure 4 demonstrates time-dependent alterations of protein-bound GSHs (GSSPs) in cytosolic and membrane RBC proteins during a 60 min exposure to BHP. 
Glutathionyl Protein Formation in RBC Fractions after Exposure to BHP
. Effects of Pre-treatment Aimed at Disrupting GSH Homeostasis on GSSG and GSSP Levels Following Exposure to BHP Two millimolars BHP was added to the RBC suspension and incubated for 1 h. GSSG (A) and protein-bound GSH (GSSP) (D) concentrations were determined in RBCs without
pretreatment. Pre-treatments: RBC suspensions (Hct. 0.50) in PBS containing 10 mM glucose were incubated in the presence of 1 mM BCNU for 30 min. After centrifugation to remove excess BCNU and re-suspension in PBS containing 10 mM glucose, each RBC suspension (Hct. 0.40) was treated with 2 mM BHP, and then GSSG (B) and GSSP (E) concentrations were determined in BCNU-treated RBCs. RBCs obtained after starvation for more than 12 h were resuspended in PBS in the absence of glucose (Hct. 0.40). After incubation at 37°C for 45 min, the RBC suspensions were further incubated with 2 mM BHP at 37°C, and then GSSG (C) and GSSP (F) concentrations were determined in glucosedeficient RBCs. GSSG and GSSP were determined (nϭ4) as described in Materials and Methods. Representative results of two independent experiments are shown. Asterisks denote significant difference versus 0 (min) ( * pϽ0.05, * * pϽ0.01).
Fig. 3. S-Glutathionylation of Human RBC Proteins after Treatment with BHP
BHP (2 mM) was added to each RBC suspension (Hct. 0.40) and incubated at 37°C. At specified time points, aliquots of suspension were withdrawn and immediately mixed with buffer for SDS-PAGE in the absence (lanes 1-4) or presence (lanes 5-8) of 0.1 M DTT. RBC proteins on the SDS-PAGE (12.5% gel) were electro-blotted onto PVDF membranes and reacted with anti-GSH monoclonal antibody, as described in the Materials and Methods. Representative results of three independent experiments are shown.
Fig. 4. Formation of GSSP in Human RBC Fractions Exposed to BHP
Protein-bound GSH (GSSP) content was determined in the cytosolic (A) and membrane (B) fractions of RBCs exposed to 2 mM BHP. BHP was added to the RBC suspensions and incubated at 37°C for 1 h. The ghost solution was used to determine the GSSP content in the membrane fraction. Values are expressed as nmol/mg protein, meanϮS.D. (nϭ4). Asterisks denote significant difference versus 0 (min) ( * pϽ0.05, * * pϽ0.01).
BHP exposure significantly promoted S-glutathionylation of both protein fractions after 5 min of incubation. Although GSSPs were mostly recovered at 60 min after treatment with BHP, more GSSPs (per mg protein) formed transiently in the membrane than in the cytosolic fraction. RBC membranes exposed to BHP were directly solubilized with SDS and subjected to SDS-PAGE under reducing and non-reducing conditions (Fig. 5) . Protein bands from the RBCs treated with BHP appeared to be almost unchanged for 1 h under reducing and non-reducing conditions (Fig. 5B) when the protein bands were visualized by CBB staining. However, decreases in bands 1, 2, and 3 were observed under non-reducing condition (Fig. 5A) . These results also indicated the status of the white ghosts that were used in the following experiments as RBC membrane samples.
When RBC suspensions were incubated with BHP in the range of 0.5-3.0 mM for 1 h, the levels of transient GSSP formation in the membrane fraction clearly increased in a BHP concentration-dependent manner (Fig. 6) . Fig. 7 , the membrane fraction prepared from whole RBCs exposed to BHP following pre-treatment with BCNU or suspension in glucose-free PBS produced similar band patterns of high molecular weight glutathionyl proteins at 5, 15, and 60 min of incubation. These results indicate that glutathionyl proteins formed by BHP exposure persisted without releasing GSH under both GSH-dependent redox system disruption conditions. Alternatively, accumulation of glutathionyl proteins was not observed without treatments using BCNU or glucose-free PBS before BHP exposure.
Effect of the Disruption of GSH Homeostasis on the Formation of Glutathionyl Proteins As shown in
Finally, we did not find clear glutathionyl protein bands, except in the high molecular weight proteins (220-240 kDa) by Western blot analysis. Thus, we further focused on the band of glutathionyl proteins obtained from the membrane in the high molecular weight range (220-240 kDa).
Identification of the Glutathionyl Proteins Formed in RBC Membranes by BHP Exposure
To identify the band of glutathionyl proteins found by Western blotting using anti-GSH antibody and anti-spectrin antibody, because the spectrin molecule contained in the membrane fraction is composed of two subunits with apparent molecular masses of 220 kDa (b-spectrin) and 240 kDa (a-spectrin), we compared the band size to native human erythroid spectrin as references. As shown in Fig. 8 , when RBC membranes prepared after exposure to BHP were analyzed by western blotting using the anti-GSH antibody against RBC membrane proteins, the band corresponding to glutathionyl proteins (lane 1) from RBC co-migrated with spectrin in same membrane preparation (lane 2) and standard spectrin a and b (lane 3).
Furthermore, we attempted the immunoprecipitation of spectrin and subsequent Western blotting using anti-GSH and anti-spectrin antibodies to identify the glutathionyl proteins. As shown in Fig. 9 , an immunoprecipited spectrin (a and b) obtained from RBC membrane exposed to 2 mM BHP for 5 min was detected by anti-GSH antibody (lane 2) and antispectrin antibody replobed after stripping procedure (lane 4). On the other hand, immunoprecipited spectrin without BHP exposure was detected by anti-spectrin antibody (lane 3) but not anti-GSH antibody (lane 1). These results demonstrated that S-glutathionylation of spectrin (a and b) occurred in RBCs that were treated with BHP in vitro.
DISCUSSION
Although GSH homeostasis is crucial to the maintenance of normal cellular physiological processes, there is little information on the exact relationship between the GSH redox state of RBCs and glutathionyl protein formation during the oxidative stress response. It was clearly shown that the reductive GSH level is strictly regulated in intact RBCs. This result indicates that it is essential to maintain the level of reductive GSH in RBCs and that the maintenance mechanism orderly acts in intact RBC suspensions in the presence of sufficient glucose. As shown in the results presented here, two independent pre-treatments aimed at disrupting GSH homeostasis 16) caused clear alterations in redox responses of RBC to BHP. GSH disruptive conditions were produced by pre-treatment with an inhibitor of GR or incubation in glucose-free medium. The latter treatment is dependent on the regulatory balance between glycolysis and the pentose phosphate pathway. Specifically, in the case of glucose deficiency, the pentose phosphate pathway is limited in producing NADPH, which is required for the GSH-dependent redox system. Thus, glucose deficiency lead to accumulation of disulfide bonds involving GSSG and glutathionyl proteins. Additionally, we added 10 mM glucose in PBS as a sufficient concentration to avoid a glucose-deficient state and to maintain redox balance. In the current study, we observed glutathionyl protein formation in human RBCs exposed to BHP when GSH homeostasis was disrupted to elucidate the relationship between the GSH-dependent redox balance and glutathionylation.
Rossi and co-workers have intensively investigated the role of protein SH groups and low molecular thiols, mainly GSH, in redox homeostasis using erythrocytes. 9, 10, 15, 23) Their results indicate a relatively limited reactivity of thiols in human hemoglobin, 23) and that the GSH-dependent redox system effectively functions 4) as a result of the marked enzymatic capacity of reducing disulfides within human RBCs.
9) It has also been shown that the GSH-dependent redox system, which utilizes Grx, G6PDH, and GR activity, is more functional in humans than in other animal species. Indeed, large amounts of glutathionyl proteins are produced in rats, but not in human RBCs, following treatment with hydroperoxides or diamide.
9) However, it is still unclear which thiol residues in proteins are protected or reversibly oxidized with immediate reactivation as a result of the GSH-dependent system in human RBCs.
We showed total proteins of the RBC membrane fractions (Fig.5 ) that were used in the examinations to detect the formation of glutathionyl proteins induced by exposure of BHP. From the observations for the typical pattern of the protein bands (numbered 1-8) shown in Fig. 5A , it appeared that degradation or aggregation involved in bands 1-4 occurred in the RBC samples.
We found that BHP exposure to RBC suspensions produced significantly more glutathionyl proteins in the membrane than in the cytosolic fraction of human RBCs (Fig. 4) , an effect that was accompanied by a decrease in GSH levels ( Fig. 1) and an increase in GSSG levels (Fig. 2) . Furthermore, our western blot analysis showed that BHP transiently generates 220-240 kDa glutathionyl proteins. However, Sglutathionyl hemoglobin, GAPDH, and actin were not detected in freshly prepared intact RBCs (Hct. 0.40), regardless of BHP exposure, using 12.5% gels for SDS-PAGE (Fig. 3) . Because the band corresponding to 220-240 kDa noted at 5 min disappeared after 1 h of incubation, the immediate recovery of glutathionyl protein to its native form by the GSHdependent redox system is likely to occur in normal human RBCs.
We identified this glutathionyl protein as spectrin (a and b) via immunoprecipitation following Western blot analysis (Fig. 9) . Spectrin is a protein expressed on the cytoplasmic surface of the membrane bilayer. It has spring-like properties that function in regulating cell shape, membrane deformability, and stability. 24) As described above, the spectrin molecules is composed of two subunits, a (240 kDa) and b (220 kDa), which are intertwined side-to-side to form a heterodimer. The two a and b subunits of spectrin are different not only in molecular mass but also in constitution. Moreover, spectrin forms noncovalent associations with other pro- teins of the cytoskeleton, such as ankylin, band 4.1 and actin, 25) as shown in Fig. 5 . Little is known about the changes or modifications in the erythrocyte membrane during ROS exposure. Recently, Mawatari et al. reported increased glutathionylation of hemoglobin in an RBC suspension (Hct. 0.10) with exposure to 1 mM BHP, which in turn reacts with an anti-GSH antibody by Western blot analysis. 14) They also indicated that membrane-associated hemoglobin, actin, spectrin, and GAPDH react with anti-GSH antibodies after incubating RBC suspensions (Hct. 0.3) for 10 min with 5 mM glucose. Moreover, Rossi et al. reported that S-glutathionyl spectrin and band 4.2 protein were detected by treatment of human RBCs with diamide. 15) However, the two reports assigned the glutathionyl proteins only by their migration on SDS-PAGE with Western blot analysis using anti-GSH antibody. To our knowledge, this study provides the first evidence indicating that glutathionyl spectrin is formed in human RBCs following BHP exposure by immunoprecipitation of anti-spectrin and reimmunoblot analysis with anti-GSH antibody.
Our results clearly show that erythroid spectrin are modified into a glutathionyl protein or glutathionyl-protein disulfide complex (GS-S-Spectrin-S-S-protein), indicating that when GSH homeostasis is disrupted for any reason, higher molecular weight glutathionyl protein accumulates in RBCs following ROS exposure (Figs. 7, 8 ). It is possible that the protection of free thiols in spectrin by glutathionylation is physiologically relevant for the function of spectrin in human RBCs. Further investigation is needed to elucidate the higher molecular weight complex containing glutathionyl spectrin and the significance of glutathionylation of spectrin found in human RBCs, which is reversible to reproduce SH-free protein.
Spectrin is an essential component of the cellular membrane skeleton. It is recognized that isoforms of spectrin are present in all cells, where they help to establish and maintain an organized distribution of membrane proteins. 26) Although we have no experimental data on this topic, the oxidative modification of spectrin in other tissues should be investigated in the near future to elucidate its significance in terms of the oxidative response of the cell.
In summary, the current study suggests that disruption of GSH homeostasis causes a significant accumulation of glutathionyl spectrin, which might reflect a physiological imbalance in the redox status in RBCs. Therefore, the finding that BHP exposure induces the formation of glutathionyl spectrin indicates its physiological significance and the specificity of glutathionylation. In addition, glutathionyl protein was not observed at least within 5 d in the normal RBCs stored at 4°C. Thus, we propose that glutathionyl spectrin can serve as a biomarker for dysfunctions in GSH homeostasis and oxidative stress within human RBCs.
